- Home
- CLNN vs MBAI Comparison
CLNN vs MBAI Comparison
Compare CLNN & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLNN | MBAI |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.4M | 49.1M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CLNN | MBAI |
|---|---|---|
| Price | $3.94 | $2.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.20 | N/A |
| AVG Volume (30 Days) | ★ 82.0K | 17.3K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $200,000.00 | N/A |
| Revenue This Year | $24.70 | $103.86 |
| Revenue Next Year | $9,228.71 | $231.30 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.02 | $0.95 |
| 52 Week High | $13.50 | $10.21 |
Technical Indicators
Market Signals| Indicator | CLNN | MBAI |
|---|---|---|
| Relative Strength Index (RSI) | 50.72 | 27.71 |
| Support Level | $3.13 | $1.33 |
| Resistance Level | $4.05 | $2.05 |
| Average True Range (ATR) | 0.28 | 0.28 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 82.61 | 6.06 |
Price Performance
Historical ComparisonAbout CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About MBAI Check-Cap Ltd. Ordinary Share
MBody AI Ltd develops enterprise software to deploy and manage autonomous robot workforces for hospitality and gaming operators. The Company's proprietary MBody AI Orchestrator is a hardware-agnostic software platform that manages diverse robot fleets from multiple vendors across sites and use cases under long-term agreements. MBody AI serves Fortune 500 operators as customers.